cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.5297620.v1
title: RAW_DataBlock_by_parameters_all_2018_10_24.mat

description: S. Cinciute, A. Daktariunas, and O. Ruksenas, “Hemodynamic effects of sex and handedness on the Wisconsin Card Sorting Test: the contradiction between neuroimaging and behavioural results” PeerJ [Internet], 2018.<br><br>Data for MATLAB
DOI: 10.6084/m9.figshare.5297656.v2
title: Processing of hybrid wood plastic composite reinforced with short PET fibers

description: Poly(ethylene terephthalate) (PET) fibers (virgin, waste, and mixed) were incorporated in the composite poly(methyl methacrylate) (PMMA)–wood. Hybrid composite panels were prepared by pressure molding. Toluene-2,4-diisocyanate (TDI) and (3-mercaptopropyl)trimethoxysilane (MPTMS) were used as cross-linking bonding agents for modification of wood fibers. Influence of cross-linking bonding agents, structure, and composition of PET fibers was examined by studying thermomechanical properties as well as moisture absorption. Moisture absorption was lower for composites with bonding agents. Mechanical testing revealed that the addition of PET fibers drastically enhances properties of the composites. Covalent and hydrogen bonds formed with the addition of bonding agents have also improved mechanical properties compared to the untreated composites.
DOI: 10.6084/m9.figshare.5297566
title: Table S1. Raw data for each behavioural category from Assessment and analysis of human laterality for manipulation and communication using the Rennes Laterality Questionnaire

description: NA: Missing value.
DOI: 10.6084/m9.figshare.5297569
title: Raw data from Community responses to seawater warming are conserved across diverse biological groupings and taxonomic resolutions

description: Assemblage-level abundance data for bacteria, protists and metazoans for each experimental treatment
DOI: 10.6084/m9.figshare.5297566.v1
title: Table S1. Raw data for each behavioural category from Assessment and analysis of human laterality for manipulation and communication using the Rennes Laterality Questionnaire

description: NA: Missing value.
DOI: 10.6084/m9.figshare.5297569.v1
title: Raw data from Community responses to seawater warming are conserved across diverse biological groupings and taxonomic resolutions

description: Assemblage-level abundance data for bacteria, protists and metazoans for each experimental treatment
DOI: 10.6084/m9.figshare.5297416
title: Inhibition of fungal pathogens across genotypes and temperatures by amphibian skin bacteria

description: Dataset consists of two sets of data files with associated R code:<br>1a) Raw plate read data titled "final_all_plates_gabe_no_contam.csv". This file consists of all OD readings for every well for every day that readings were taken. We used R code to correct baseline zoospore OD, fit a linear regression to the OD readings over time, remove wells with low r2 values, and calculate inhibition scores<br>1b) R code to work with the "final_all_plates...csv is titled "Calculate_score_inhibit_final.R"<br>2a) The inhibition scores for each well titled "Inhibition_scores.final.csv". This is the output of the R code above. We did edit this file in excel to add a genotype column that is not in the R code<br>2b) The averages of inhibition scores used to make the heatmap figure titled "heatmap_averages_final.csv". See more details in the associated .Rmd file to see how we generated these values. <br>2c) R code to do analyses of inhibition scores and make figures titled "Publish_Bac_Temp_BdBsal.Rmd"<br>2d) The knitted .Rmd file titled "Publish_Bac_Temp_BdBsal.html"
DOI: 10.6084/m9.figshare.5297443
title: Supplementary Material for: Microvessel Density as a Surrogate Prognostic Marker in Patients with Multiple Myeloma: A Meta-Analysis

description: <b><i>Background/Aims:</i></b> Bone marrow (BM) angiogenesis is considered a hallmark of multiple myeloma (MM) development and progression, and can be quantified with the use of microvessel density (MVD). The purpose of this study is to provide a review and a meta-analysis of the current literature regarding the prognostic value of MVD in the overall survival (OS) of MM patients. <b><i>Methods:</i></b> MEDLINE was screened for studies evaluating the OS of MM patients with regard to their MVD count in BM trephine. The pooled hazard ratio (HR) and its associated 95% confidence interval (CI) among MM patients with a high and low MVD count was the primary end point. Secondary outcomes included odds ratios (OR) for 12-, 36-, and 60-month survival. <b><i>Results:</i></b> Ten eligible trials were identified for the analysis of the primary end point and 9 for the secondary end points. Pooled HR for OS was 1.85 (95% CI: 1.25-2.73, <i>p</i> = 0.002). The pooled OR of survival were 1.59 (95% CI: 1.02-2.46, <i>p</i> = 0.04) at 12 months, 2.90 (95% CI: 1.68-5.03, <i>p</i> = 0.0001) at 36 months, and 3.42 (95% CI: 2.41-4.85, <i>p</i> &lt; 0.00001) at 60 months, in favor of the low MVD group. <b><i>Conclusion:</i></b> This meta-analysis provides persuasive evidence that MVD has significant impact on the clinical outcome of MM patients.
DOI: 10.6084/m9.figshare.5297389.v1
title: IoT Applied Solution: Prototyping the prototype

description: IoT applications can vary widely depending on the industry type. Most of these projects are SDK based. In order to begin outlining the potential of many of these IoT applications, the very prototype plan needs a jump-start. Some of the simulation are conceived in a simplistic Excel like system that will identify the system variables and expected outcome to discover the end application.
DOI: 10.6084/m9.figshare.5297374.v2
title: DIPLOS FlowViz full resolution

description: Full resolution videos of the DIPLOS flow visualisation experiments. All the other content mentioned in the ReadMe file is actually stored in the other dataset: "DIPLOS FlowVis catalogue"<br><br>
DOI: 10.6084/m9.figshare.5297245
title: DIPLOS final

description: Final dataset for the DIPLOS project - All the data<br>
DOI: 10.6084/m9.figshare.5297251
title: Gwas imputated data

description: Gwas imputated dataset for growth traits in <i>Salmo salar.</i>
DOI: 10.6084/m9.figshare.5297221
title: Cophylogenetic analyses reveal extensive host-shift speciation in a highly specialized and host-specific symbiont system

description: mtgenomes_fasta: Mitochondrial genomes assembled for this study. Proctophyllodes: Protein-coding gene aligments plus concatenated aligment. Trouessartia: Protein-coding gene aligments plus concatenated aligment.
DOI: 10.6084/m9.figshare.5297221.v1
title: Cophylogenetic analyses reveal extensive host-shift speciation in a highly specialized and host-specific symbiont system

description: mtgenomes_fasta: Mitochondrial genomes assembled for this study. Proctophyllodes: Protein-coding gene aligments plus concatenated aligment. Trouessartia: Protein-coding gene aligments plus concatenated aligment.
DOI: 10.6084/m9.figshare.5297086
title: Leaf odour cues and foraging by mammalian herbivores

description: Data for Finnerty, P.B., Stutz, R.S., Price, C.J., Banks, P.B. & McArthur, C. (2017) Leaf odour cues enable non-random foraging by mammalian herbivores. Journal of Animal Ecology.<br>
DOI: 10.6084/m9.figshare.5297065
title: S1 data (EGFR wildtype mutation).xls

description: the primary data of included ADC patients with EGFR wildtype mutation
DOI: 10.6084/m9.figshare.5297056
title: The efficacy and feasibility of aquatic physiotherapy for people with Parkinson’s disease: a systematic review

description: <b>Purpose:</b> To critically evaluate the literature regarding the efficacy and feasibility of aquatic physiotherapy in people with Parkinson’s disease. <b>Method:</b> Relevant studies were identified through searches in nine health-related databases. Two independent reviewers assessed study quality using either the PEDro scale or a customised tool for safety and feasibility. <b>Results:</b> Database searches yielded 88 articles, of which 10 met the inclusion criteria. Studies varied greatly in methodology, quality, interventions and outcome measures. Study quality was generally low in items reporting on safety precautions, adverse events, attrition, and adherence. Results suggest that aquatic physiotherapy may have a positive effect on motor symptoms, quality of life and balance. <b>Conclusions:</b> Aquatic physiotherapy may improve aspects of motor performance, quality of life and balance in people with Parkinson’s disease, however, it remains unclear whether it is a safe and feasible treatment modality. The development of standardised outcome measures for people with Parkinson’s disease (unified Parkinson’s disease rating scale and Parkinson’s disease questionnaire-39) would aid study comparability and validate study outcomes. As safety criteria was grossly underreported, guidelines for mandatory reporting of safety criteria are essential to make conclusions regarding the feasibility of aquatic physiotherapy for people with Parkinson’s disease.Implications for RehabilitationAquatic physiotherapy may be a beneficial treatment modality for people with Parkinson’s disease.A minimum data set that includes the unified Parkinson’s disease rating scale and Parkinson’s disease questionnaire 39 is required to aid future meta-analysis and to allow more definitive conclusions to be made regarding aquatic physiotherapy for people with Parkinson’s disease.People with Parkinson’s disease are a vulnerable population, where safety within an aquatic physiotherapy program needs to be well documented and addressed. Aquatic physiotherapy may be a beneficial treatment modality for people with Parkinson’s disease. A minimum data set that includes the unified Parkinson’s disease rating scale and Parkinson’s disease questionnaire 39 is required to aid future meta-analysis and to allow more definitive conclusions to be made regarding aquatic physiotherapy for people with Parkinson’s disease. People with Parkinson’s disease are a vulnerable population, where safety within an aquatic physiotherapy program needs to be well documented and addressed.
DOI: 10.6084/m9.figshare.5297056.v1
title: The efficacy and feasibility of aquatic physiotherapy for people with Parkinson’s disease: a systematic review

description: <b>Purpose:</b> To critically evaluate the literature regarding the efficacy and feasibility of aquatic physiotherapy in people with Parkinson’s disease. <b>Method:</b> Relevant studies were identified through searches in nine health-related databases. Two independent reviewers assessed study quality using either the PEDro scale or a customised tool for safety and feasibility. <b>Results:</b> Database searches yielded 88 articles, of which 10 met the inclusion criteria. Studies varied greatly in methodology, quality, interventions and outcome measures. Study quality was generally low in items reporting on safety precautions, adverse events, attrition, and adherence. Results suggest that aquatic physiotherapy may have a positive effect on motor symptoms, quality of life and balance. <b>Conclusions:</b> Aquatic physiotherapy may improve aspects of motor performance, quality of life and balance in people with Parkinson’s disease, however, it remains unclear whether it is a safe and feasible treatment modality. The development of standardised outcome measures for people with Parkinson’s disease (unified Parkinson’s disease rating scale and Parkinson’s disease questionnaire-39) would aid study comparability and validate study outcomes. As safety criteria was grossly underreported, guidelines for mandatory reporting of safety criteria are essential to make conclusions regarding the feasibility of aquatic physiotherapy for people with Parkinson’s disease.Implications for RehabilitationAquatic physiotherapy may be a beneficial treatment modality for people with Parkinson’s disease.A minimum data set that includes the unified Parkinson’s disease rating scale and Parkinson’s disease questionnaire 39 is required to aid future meta-analysis and to allow more definitive conclusions to be made regarding aquatic physiotherapy for people with Parkinson’s disease.People with Parkinson’s disease are a vulnerable population, where safety within an aquatic physiotherapy program needs to be well documented and addressed. Aquatic physiotherapy may be a beneficial treatment modality for people with Parkinson’s disease. A minimum data set that includes the unified Parkinson’s disease rating scale and Parkinson’s disease questionnaire 39 is required to aid future meta-analysis and to allow more definitive conclusions to be made regarding aquatic physiotherapy for people with Parkinson’s disease. People with Parkinson’s disease are a vulnerable population, where safety within an aquatic physiotherapy program needs to be well documented and addressed.
DOI: 10.6084/m9.figshare.5297032.v3
title: sensory_PAC - scripts for calculating Phase Amplitude Coupling

description: MATLAB scripts for detecting and validating phase amplitude coupling (PAC) in electrophysiological data
DOI: 10.6084/m9.figshare.12382874
title: Cost-effectiveness analysis of pembrolizumab monotherapy versus chemotherapy for previously untreated advanced non-small cell lung cancer

description: <b>Objective:</b> To assess the cost-effectiveness of pembrolizumab monotherapy compared with standard chemotherapy for the treatment of advanced non-small cell lung cancer (NSCLC) in previously untreated adults who have a high programmed death ligand 1 (PD-L1) tumor proportion score of 50% or greater in Singapore. <b>Materials and methods:</b> A partitioned-survival analysis model was developed from a healthcare system’s perspective that extrapolated clinical and economic outcomes of first-line pembrolizumab (maximum treatment duration of 2 years) versus platinum doublet chemotherapy over a 10-year time horizon for patients with advanced NSCLC. The model consisted of three health states: alive with no progression, alive with progression, and dead. Key clinical inputs were based on Kaplan-Meier survival curves from the interim (median follow-up = 11.2 months) and updated analysis (median follow-up = 25.2 months) of the KEYNOTE-024 randomized controlled trial. Local cost data were applied. Utilities were derived from published international estimates. Both one-way and multivariate probabilistic sensitivity analyses (PSA) were conducted to identify key drivers of the results. <b>Results:</b> Using the results from the updated analysis of KEYNOTE-024, patients treated with pembrolizumab experienced more quality adjusted life-years (QALYs), but incurred higher costs compared to chemotherapy over a 10-year time horizon (pembrolizumab: 1.9983 QALYs, SGD215,761; chemotherapy: 1.1317 QALYs, SGD70,444). The base-case incremental cost-effectiveness ratio (ICER) was SGD167,692 per QALY gained. One-way sensitivity analysis showed the ICER was most sensitive to the cost of pembrolizumab, followed by the time horizon. Multivariate PSA indicated that pembrolizumab had 0% probability of being cost-effective at a hypothetical willingness-to-pay threshold of SGD100,000 per QALY gained. <b>Conclusion:</b> While pembrolizumab is superior to standard chemotherapy in improving overall survival and progression-free survival, results suggest that it is unlikely to be cost-effective at its current price in Singapore. Factors including clinical effectiveness, safety, and budget impact should also be considered when making national funding decisions.
DOI: 10.6084/m9.figshare.12382874.v1
title: Cost-effectiveness analysis of pembrolizumab monotherapy versus chemotherapy for previously untreated advanced non-small cell lung cancer

description: <b>Objective:</b> To assess the cost-effectiveness of pembrolizumab monotherapy compared with standard chemotherapy for the treatment of advanced non-small cell lung cancer (NSCLC) in previously untreated adults who have a high programmed death ligand 1 (PD-L1) tumor proportion score of 50% or greater in Singapore. <b>Materials and methods:</b> A partitioned-survival analysis model was developed from a healthcare system’s perspective that extrapolated clinical and economic outcomes of first-line pembrolizumab (maximum treatment duration of 2 years) versus platinum doublet chemotherapy over a 10-year time horizon for patients with advanced NSCLC. The model consisted of three health states: alive with no progression, alive with progression, and dead. Key clinical inputs were based on Kaplan-Meier survival curves from the interim (median follow-up = 11.2 months) and updated analysis (median follow-up = 25.2 months) of the KEYNOTE-024 randomized controlled trial. Local cost data were applied. Utilities were derived from published international estimates. Both one-way and multivariate probabilistic sensitivity analyses (PSA) were conducted to identify key drivers of the results. <b>Results:</b> Using the results from the updated analysis of KEYNOTE-024, patients treated with pembrolizumab experienced more quality adjusted life-years (QALYs), but incurred higher costs compared to chemotherapy over a 10-year time horizon (pembrolizumab: 1.9983 QALYs, SGD215,761; chemotherapy: 1.1317 QALYs, SGD70,444). The base-case incremental cost-effectiveness ratio (ICER) was SGD167,692 per QALY gained. One-way sensitivity analysis showed the ICER was most sensitive to the cost of pembrolizumab, followed by the time horizon. Multivariate PSA indicated that pembrolizumab had 0% probability of being cost-effective at a hypothetical willingness-to-pay threshold of SGD100,000 per QALY gained. <b>Conclusion:</b> While pembrolizumab is superior to standard chemotherapy in improving overall survival and progression-free survival, results suggest that it is unlikely to be cost-effective at its current price in Singapore. Factors including clinical effectiveness, safety, and budget impact should also be considered when making national funding decisions.
DOI: 10.6084/m9.figshare.5296426
title: Supplementary Table 1. Impoundments Surveyed from 2012-2016. The first time an impoundment is mentioned the latitude, longitude of the center of the impoundment is given.

description: Supplementary Table 1. Impoundments Surveyed from 2012-2016. The first time an impoundment is mentioned the latitude, longitude of the center of the impoundment is given. <br><br>from <br>Fournier, A.M.V., Mengel, D.C., Krementz, D.G. In Press <em>Virginia and Yellow Rail autumn migration ecology: synthesis using multiple data sets</em> Animal Migration DOI: 10.1515/ami-2017-0003<br>
DOI: 10.6084/m9.figshare.5296453
title: Supplementary Table 2. Phenology data for Yellow Rail and Virginia Rail from This Study and Opportunistic Sources

description: Supplementary Table 2. Phenology data for Yellow Rail and Virginia Rail from This Study and Opportunistic Sources <br>From :<br>Fournier, A.M.V., Mengel, D.C., Krementz, D.G. In Press <em>Virginia and Yellow Rail autumn migration ecology: synthesis using multiple data sets</em> Animal MigrationDOI: 10.1515/ami-2017-0003 <br>
DOI: 10.6084/m9.figshare.5296411
title: Supplementary Data 3. Yellow Rail raw vegetation data with random points and used points from Missouri, USA 2012-2016.

description: Supplementary Data 3. Yellow Rail raw vegetation data with random points and used points from Missouri, USA 2012-2016. <br><br>From Fournier, A.M.V., Mengel, D.C., Krementz, D.G. In Press <em>Virginia and Yellow Rail autumn migration ecology: synthesis using multiple data sets</em> Animal Migration DOI: 10.1515/ami-2017-0003
DOI: 10.6084/m9.figshare.5296453.v1
title: Supplementary Table 2. Phenology data for Yellow Rail and Virginia Rail from This Study and Opportunistic Sources

description: Supplementary Table 2. Phenology data for Yellow Rail and Virginia Rail from This Study and Opportunistic Sources <br>From :<br>Fournier, A.M.V., Mengel, D.C., Krementz, D.G. In Press <em>Virginia and Yellow Rail autumn migration ecology: synthesis using multiple data sets</em> Animal MigrationDOI: 10.1515/ami-2017-0003 <br>
DOI: 10.6084/m9.figshare.5296387
title: Supplementary Data 1. Summary of vegetation data for random, and used point for Yellow Rail and Virginia Rail from Missouri, USA from 2012-2016.

description: Supplementary Data 1. Summary of vegetation data for random, and used point for Yellow Rail and Virginia Rail from Missouri, USA from 2012-2016.<br>From <br> Fournier, A.M.V., Mengel, D.C., Krementz, D.G. In Press <em>Virginia and Yellow Rail autumn migration ecology: synthesis using multiple data sets</em> Animal Migration DOI: 10.1515/ami-2017-0003
DOI: 10.6084/m9.figshare.5296402
title: Supplementary Data 2. Virginia Rail raw vegetation data with random points and used points from Missouri, USA 2012-2016tem

description: Supplementary Data 2. Virginia Rail raw vegetation data with random points and used points from Missouri, USA 2012-2016 <br>From <br> Fournier, A.M.V., Mengel, D.C., Krementz, D.G. In Press <em>Virginia and Yellow Rail autumn migration ecology: synthesis using multiple data sets</em> Animal Migration DOI: 10.1515/ami-2017-0003<br>
DOI: 10.6084/m9.figshare.5296426.v1
title: Supplementary Table 1. Impoundments Surveyed from 2012-2016. The first time an impoundment is mentioned the latitude, longitude of the center of the impoundment is given.

description: Supplementary Table 1. Impoundments Surveyed from 2012-2016. The first time an impoundment is mentioned the latitude, longitude of the center of the impoundment is given. <br><br>from <br>Fournier, A.M.V., Mengel, D.C., Krementz, D.G. In Press <em>Virginia and Yellow Rail autumn migration ecology: synthesis using multiple data sets</em> Animal Migration DOI: 10.1515/ami-2017-0003<br>
DOI: 10.6084/m9.figshare.5296387.v1
title: Supplementary Data 1. Summary of vegetation data for random, and used point for Yellow Rail and Virginia Rail from Missouri, USA from 2012-2016.

description: Supplementary Data 1. Summary of vegetation data for random, and used point for Yellow Rail and Virginia Rail from Missouri, USA from 2012-2016.<br>From <br> Fournier, A.M.V., Mengel, D.C., Krementz, D.G. In Press <em>Virginia and Yellow Rail autumn migration ecology: synthesis using multiple data sets</em> Animal Migration DOI: 10.1515/ami-2017-0003
DOI: 10.6084/m9.figshare.5296402.v1
title: Supplementary Data 2. Virginia Rail raw vegetation data with random points and used points from Missouri, USA 2012-2016tem

description: Supplementary Data 2. Virginia Rail raw vegetation data with random points and used points from Missouri, USA 2012-2016 <br>From <br> Fournier, A.M.V., Mengel, D.C., Krementz, D.G. In Press <em>Virginia and Yellow Rail autumn migration ecology: synthesis using multiple data sets</em> Animal Migration DOI: 10.1515/ami-2017-0003<br>
DOI: 10.6084/m9.figshare.5296411.v1
title: Supplementary Data 3. Yellow Rail raw vegetation data with random points and used points from Missouri, USA 2012-2016.

description: Supplementary Data 3. Yellow Rail raw vegetation data with random points and used points from Missouri, USA 2012-2016. <br><br>From Fournier, A.M.V., Mengel, D.C., Krementz, D.G. In Press <em>Virginia and Yellow Rail autumn migration ecology: synthesis using multiple data sets</em> Animal Migration DOI: 10.1515/ami-2017-0003